↓ Skip to main content

Cost–effectiveness of a comprehensive programme for drug-resistant tuberculosis in China

Overview of attention for article published in Bulletin of the World Health Organization, September 2015
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (61st percentile)

Mentioned by

policy
1 policy source

Citations

dimensions_citation
7 Dimensions

Readers on

mendeley
76 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Cost–effectiveness of a comprehensive programme for drug-resistant tuberculosis in China
Published in
Bulletin of the World Health Organization, September 2015
DOI 10.2471/blt.14.146274
Pubmed ID
Authors

Christopher Fitzpatrick, Zhang Hui, Wang Lixia, Li Renzhong, Ruan Yunzhou, Chen Mingting, Zhao Yanlin, Zhao Jin, Su Wei, Xu Caihong, Chen Cheng, Timothy Alston, Qu Yan, Lv Chengfei, Fu Yunting, Huan Shitong, Sun Qiang, Fabio Scano, Daniel P Chin, Katherine Floyd

Abstract

To investigate the cost-effectiveness of a comprehensive programme for drug-resistant tuberculosis launched in four sites in China in 2011. In 2011-2012, we reviewed the records of 172 patients with drug-resistant tuberculosis who enrolled in the comprehensive programme and we collected relevant administrative data from hospitals and China's public health agency. For comparison, we examined a cohort of 81 patients who were treated for drug-resistant tuberculosis in 2006-2009. We performed a cost-effectiveness analysis, from a societal perspective, that included probabilistic uncertainty. We measured early treatment outcomes based on three-month culture results and modelled longer-term outcomes to facilitate estimation of the comprehensive programme's cost per disability-adjusted life-year (DALY) averted. The comprehensive programme cost 8837 United States dollars (US$) per patient treated. Low enrolment rates meant that some fixed costs were higher, per patient, than expected. Although the comprehensive programme appeared 30 times more costly than the previous one, it resulted in greater health benefits. The comprehensive programme, which cost US$ 639 (95% credible interval: 112 to 1322) per DALY averted, satisfied the World Health Organization's criterion for a very cost-effective intervention. The comprehensive programme, which included rapid screening, standardized care and financial protection, improved individual outcomes for MDR tuberculosis in a cost-effective manner. To support post-2015 global heath targets, the comprehensive programme should be expanded to non-residents and other areas of China.

Mendeley readers

The data shown below were compiled from readership statistics for 76 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 1%
Canada 1 1%
South Africa 1 1%
Unknown 73 96%

Demographic breakdown

Readers by professional status Count As %
Student > Master 14 18%
Researcher 14 18%
Student > Ph. D. Student 7 9%
Student > Doctoral Student 6 8%
Other 5 7%
Other 15 20%
Unknown 15 20%
Readers by discipline Count As %
Medicine and Dentistry 21 28%
Economics, Econometrics and Finance 8 11%
Pharmacology, Toxicology and Pharmaceutical Science 6 8%
Social Sciences 6 8%
Nursing and Health Professions 5 7%
Other 8 11%
Unknown 22 29%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 November 2015.
All research outputs
#4,467,543
of 14,573,919 outputs
Outputs from Bulletin of the World Health Organization
#1,362
of 2,775 outputs
Outputs of similar age
#96,736
of 265,836 outputs
Outputs of similar age from Bulletin of the World Health Organization
#29
of 43 outputs
Altmetric has tracked 14,573,919 research outputs across all sources so far. This one is in the 49th percentile – i.e., 49% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,775 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.1. This one is in the 13th percentile – i.e., 13% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 265,836 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.
We're also able to compare this research output to 43 others from the same source and published within six weeks on either side of this one. This one is in the 2nd percentile – i.e., 2% of its contemporaries scored the same or lower than it.